The goal of this program is to improve management of myeloprolif erative neoplasm (MPN) and smoldering multiple myeloma (SMM). After hearing and assimilating this program, the clinician will be better able to: 1. Select therapies to reduce risk for progression in patients with MPN. 2. Relate use of janus kinase inhibitors to increases in hemoglobin levels. 3. Devise dosing regimens for interferon-based therapies for polycythemia vera. 4. Identify patients with SMM at increased risk for progression of disease. 5. Choose an imaging modality for assessment of risk for pro gression in SMM.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2024-05-30 05:00:00
- End Date: 2024-05-30 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABIM - 2.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest